TRPV1 modulators can enhance the effect of chemoradiotherapy, and the synergistic use of TRPV1 modulator can reduce the required dose of chemoradiotherapy to control cancer and reduce the toxic side effects of chemoradiotherapy. This evidence concerns the gene TRPV1 and cancer.